Tosoh Bioscience Acquires Semba Biosciences

Tosoh Bioscience LLC (King of Prussia, Pennsylvania), a supplier of separation and purification products and technologies to the life sciences industry, has acquired Semba Biosciences, a privately held company located in Madison, Wisconsin. Semba is a developer in the field of multicolumn chromatography instrumentation and technology for downstream purification of biologics.

Ali Soleymannezhad, Tosoh’s vice president of global marketing and business development said in a statement that he was “thrilled” to welcome the Semba Biosciences team to the Tosoh family. “For long we have admired Semba’s technology and innovation, pioneering the simulated moving bed (SMB) technology in the biopurification process.” He said that the acquisition marks a new era for Tosoh Bioscience and confirms Tosoh’s commitment to provide customers with the latest solutions and technologies.

Semba President and Chief Executive Officer, Robert Mierendorf expressed the company’s excitement about becoming part of the Tosoh worldwide organization. In a statement, he said, “By combining Semba Biosciences’ advanced SMB technology with Tosoh Bioscience’s best-in-class resins, we will be able to offer unparalleled efficiency and productivity in downstream processes and significantly decrease the cost of manufacturing.”

Tosoh plans to expand the current Semba team in Madison to create a global center of excellence for continuous chromatography.